Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita

Human Genetics

Volumn 115, Issue 5, 2004, Pages 448-455

  Wong, Judy M Y ^a   Kyasa, Mouhammed J ^b   Hutchins, Laura ^b   Collins, Kathleen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TELOMERASE;

ADULT; ARTICLE; CASE REPORT; CELL CULTURE; DYSKERATOSIS CONGENITA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; FAMILY; HEMATOPOIETIC SYSTEM; HETEROZYGOTE; HUMAN; LYMPHOBLAST; LYMPHOCYTE; LYMPHOID CELL; MALE; MOTHER; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; X CHROMOSOME LINKAGE;

ADULT; BLOTTING, NORTHERN; CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; DYSKERATOSIS CONGENITA; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TELOMERASE;

EID: 5044251217     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-004-1178-7     Document Type: Article

References (31)

1. Bachellerie JP, Cavaille J, Huttenhofer A (2002) The expanding snoRNA world. Biochimie 84:775-790
2. Blackburn EH (2000) The end of the (DNA) line. Nat Struct Biol 7: 847-850
3. Blasco MA, Hahn WC (2003) Evolving views of telomerase and cancer. Trends Cell Biol 13:289-294
4. Broccoli D, Godley LA, Donehower LA, Varmus HE, Lange T de (1996) Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol Cell Biol 16:3765-3772
5. Collins K, Mitchell JR (2002) Telomerase in the human organism. Oncogene 21:564-579
6. Dokal I, Vulliamy T (2003) Dyskeratosis congenita: its link to telomerase and aplastic anaemia. Blood Rev 17:217-225
7. Dragon F, Pogacic V, Filipowicz W (2000) In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs. Mol Cell Biol 20:3037-3048
8. Filipowicz W, Pogacic V (2002) Biogenesis of small nucleolar ribonucleoproteins. Curr Opin Cell Biol 14:319-327
9. Filipowicz W, Pelczar P, Pogacic V, Dragon F (1999) Structure and biogenesis of small nucleolar RNAs acting as guides for ribosomal RNA modification. Acta Biochim Pol 46:377-389
10. Fogarty PF, Yamaguchi H, Wiestner A, Baerlocher GM, Sloand E, Zeng WS, Read EJ, Lansdorp PM, Young NS (2003) Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet 262:1628-1630
11. Fu D, Collins K (2003) Distinct biogenesis pathways for human telomerase RNA and H/ACA small nucleolar RNAs. Mol Cell 11:1361-1372
12. Greenwood MJ, Lansdorp PM (2003) Telomeres, telomerase, and hematopoietic stem cell biology. Arch Med Res 34:489-495
13. Hann B, Balmain A (2001) Building "validated" mouse models of human cancer. Curr Opin Cell Biol 13:778-784
14. Harrington L (2003) Biochemical aspects of telomerase function. Cancer Lett 194:139-154
15. He J, Navarrete S, Jasinski M, Vulliamy T, Dokal I, Bessler M, Mason PJ (2002) Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene 21:7740-7744
16. Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I (1998) X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 19:32-38
17. Marrone A, Mason PJ (2003) Dyskeratosis congenita. Cell Mol Life Sci 60:507-517
18. Mason PJ (2003) Stem cells, telomerase and dyskeratosis congenita. Bioessays 25:126-133
19. Mitchell JR, Collins K (2000) Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase in vivo and in vitro. Mol Cell 6:361-371
20. Mitchell JR, Cheng J, Collins K (1999a) A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3′ end. Mol Cell Biol 19:567-576
21. Mitchell JR, Wood E, Collins K (1999b) A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402:551-555
22. Montanaro L, Chilla A, Trere D, Pession A, Govoni M, Tazzari PL, Derenzini M (2002) Increased mortality rate and not impaired ribosomal biogenesis is responsible for proliferative defect in dyskeratosis congenita cell lines. J Invest Dermatol 118:193-198
23. Ogoshi M, Le T, Shay JW, Taylor RS (1998) In situ hybridization analysis of the expression of human telomerase RNA in normal and pathologic conditions of the skin. J Invest Dermatol 110:818-823
24. Pogacic V, Dragon F, Filipowicz W (2000) Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10. Mol Cell Biol 20:9028-9040
25. Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, Rao PH, Cordon-Cardo C, Pandolfi PP (2003) Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299:259-262
26. Vulliamy TJ, Knight SW, Dokal I, Mason PJ (1997) Skewed X-inactivation in carriers of X-linked dyskeratosis congenita. Blood 90:2213-2216
27. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I (2001a) The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413:432-435
28. Vulliamy TJ, Knight SW, Mason PJ, Dokal I (2001b) Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis 27:353-357
29. Vulliamy TJ, Marrone A, Dokal I, Mason PJ (2002) Association between aplastic anemia and mutations in telomerase RNA. Lancet 359:2168-2170
30. Wong JMY, Collins K (2003) Telomere maintenance and disease. Lancet 362:983-988
31. Wong JM, Kusdra L, Collins K (2002) Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat Cell Biol 4:731-736